Glibenclamide And Metformin Oral Tablets (Immediate-Release) Suppliers & Bulk Manufacturers
Available Forms: Tablets IR
Available Strengths: Glibenclamide 2.5 mg + Metformin 500 mg; Glibenclamide 5 mg + Metformin 500 mg
Reference Brands: Glucovance®,®, Euglucon-M®, Glyburid-M®(EU & US)
Category: Diabetes
This dual formulation combines Glibenclamide, a sulfonylurea that stimulates insulin secretion, and Metformin, which reduces hepatic glucose production and improves insulin sensitivity. The synergistic effect offers better glycemic control in type 2 diabetes, reducing fasting and postprandial glucose levels. It lowers HbA1c effectively and is suitable when monotherapy fails.
Product Description: Glibenclamide (Glyburide) + Metformin tablets are approved in several EU countries under fixed-dose combinations and were previously marketed in the USA as Glucovance®. However, due to evolving safety guidelines—especially related to hypoglycemia risk—its availability may vary. In the EU, these combinations are still prescribed under close monitoring for type 2 diabetes management. The European Medicines Agency (EMA) requires risk-benefit evaluation and labeling for renal monitoring. The U.S. FDA formerly approved Glucovance® under NDA 021178. Healthcare buyers and distributors can find these formulations via Pharmatradz.com for compliant global sourcing.
Glibenclamide And Metformin Oral Tablets (Immediate-Release) — third party manufacturing & bulk supply
Glibenclamide And Metformin Oral Tablets (Immediate-Release) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Glibenclamide And Metformin Oral Tablets (Immediate-Release) is supplied as Tablets IR — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Glibenclamide And Metformin Oral Tablets (Immediate-Release) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Glibenclamide And Metformin Oral Tablets... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
